Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Kaposi's sarcoma and human dermal microvascular endothelial cells infected with Kaposi's sarcoma-associated herpesvirus express CCL21.

Literature DB >> 21176872

Kaposi's sarcoma and human dermal microvascular endothelial cells infected with Kaposi's sarcoma-associated herpesvirus express CCL21.

Makoto Sugaya, Stacy Reed, Patrick P Rose, Stacy de la Motte, Camilo M Raggo, Stephen E Kurtz, Ashlee V Moses, Klaus Früh, Andrew Blauvelt.

Abstract

Entities: CellLine Chemical Disease Gene Species

Mesh：

Substances：

Year: 2010 PMID： 21176872 PMCID： PMC3399906 DOI： 10.1016/j.jdermsci.2010.11.017

Source DB: PubMed Journal: J Dermatol Sci ISSN： 0923-1811 Impact factor: 4.563

Keyword Cloud
References

× No keyword cloud information.

10 in total

Review 1. Cytokines and growth factors in the pathogenesis of AIDS-associated Kaposi's sarcoma.

Authors: B Ensoli; G Barillari; R C Gallo
Journal: Immunol Rev Date: 1992-06 Impact factor: 12.988

2. Oncostatin M enhances CCL21 expression by microvascular endothelial cells and increases the efficiency of dendritic cell trafficking to lymph nodes.

Authors: Makoto Sugaya; Lei Fang; Adela R Cardones; Takashi Kakinuma; Samer H Jaber; Andrew Blauvelt; Sam T Hwang
Journal: J Immunol Date: 2006-12-01 Impact factor: 5.422

3. Chemokine receptor CCR7 required for T lymphocyte exit from peripheral tissues.

Authors: Gudrun F Debes; Carrie N Arnold; Alan J Young; Stefan Krautwald; Martin Lipp; John B Hay; Eugene C Butcher
Journal: Nat Immunol Date: 2005-08-14 Impact factor: 25.606

4. A Kaposi's sarcoma complete clinical response after sorafenib administration.

Authors: A Ardavanis; D Doufexis; P Kountourakis; G Rigatos
Journal: Ann Oncol Date: 2008-07-22 Impact factor: 32.976

5. Long-term infection and transformation of dermal microvascular endothelial cells by human herpesvirus 8.

Authors: A V Moses; K N Fish; R Ruhl; P P Smith; J G Strussenberg; L Zhu; B Chandran; J A Nelson
Journal: J Virol Date: 1999-08 Impact factor: 5.103

6. Lymphatic dysfunction in transgenic mice expressing KSHV k-cyclin under the control of the VEGFR-3 promoter.

Authors: Makoto Sugaya; Takahiro Watanabe; Aparche Yang; Matthew F Starost; Hisataka Kobayashi; April M Atkins; Debra L Borris; Elisabeth A Hanan; Daniel Schimel; Mark A Bryant; Nicole Roberts; Mihaela Skobe; Katherine A Staskus; Philipp Kaldis; Andrew Blauvelt
Journal: Blood Date: 2004-11-09 Impact factor: 22.113

Kaposi's sarcoma and human dermal microvascular endothelial cells infected with Kaposi's sarcoma-associated herpesvirus express CCL21.

Review 1. Cytokines and growth factors in the pathogenesis of AIDS-associated Kaposi's sarcoma.

2. Oncostatin M enhances CCL21 expression by microvascular endothelial cells and increases the efficiency of dendritic cell trafficking to lymph nodes.

3. Chemokine receptor CCR7 required for T lymphocyte exit from peripheral tissues.

4. A Kaposi's sarcoma complete clinical response after sorafenib administration.

5. Long-term infection and transformation of dermal microvascular endothelial cells by human herpesvirus 8.

6. Lymphatic dysfunction in transgenic mice expressing KSHV k-cyclin under the control of the VEGFR-3 promoter.

7. Secondary lymphoid-tissue chemokine is a functional ligand for the CC chemokine receptor CCR7.

8. Oncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells.

9. Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus.

10. Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells.